We recently published a list of S&P 500 Dividend Aristocrats List: Sorted By Hedge Fund Sentiment. In this article, we are ...

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $166.09, denoting a +1.44% change from the preceding trading day.

Escalating concerns over impending tariffs and President Trump's foreign policies have fueled uncertainty and instability in ...

Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...

Johnson & Johnson (NYSE:JNJ) is suing Samsung Bioepis for breach of contract related to the launch of a biosimilar of J&J's ...

Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...

The Japanese Ministry of Health, Labor and Welfare (MHLW) in Japan has approved Sarclisa (isatuximab), in combination with ...

Nasdaq 100, S&P 500, Dow Jones Industrial Average, Coca-Cola Co. Read MarketBeat.com (Ryan Hasson)'s latest article on Investing.com ...

"The demand environment remains consistent with our view of a gradual recovery in 2025," said CEO Satish Dhanasekaran.

Axon expects full-year 2025 revenue to be between $2.55 billion and $2.65 billion, the midpoint of which is higher than ...

The geopolitical landscape has drastically changed since the beginning of the decade, with the COVID-19 pandemic followed by ...